101 related articles for article (PubMed ID: 37610042)
21. Racial, ethnic, and socioeconomic disparities impact post-liver transplant survival in patients with hepatocellular carcinoma.
Huang DC; Yu RL; Alqahtani S; Tamim H; Saberi B; Bonder A
Ann Hepatol; 2023; 28(5):101127. PubMed ID: 37286167
[TBL] [Abstract][Full Text] [Related]
22. Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States.
Ahn JC; Lauzon M; Luu M; Noureddin M; Ayoub W; Kuo A; Sundaram V; Kosari K; Nissen N; Gong J; Hendifar A; Roberts LR; Abou-Alfa GK; Singal AG; Yang JD
Hepatology; 2022 Dec; 76(6):1649-1659. PubMed ID: 35429171
[TBL] [Abstract][Full Text] [Related]
23. Palliative care utilization and racial and ethnic disparities among women with de novo metastatic breast cancer in the United States.
Giap F; Ma SJ; Oladeru OT; Hong YR; Yu B; Mailhot Vega RB; Brooks ED; Singh AK; Okunieff PG; Mendenhall NP; Bradley JA
Breast Cancer Res Treat; 2023 Aug; 200(3):347-354. PubMed ID: 37269438
[TBL] [Abstract][Full Text] [Related]
24. Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis.
Rich NE; Carr C; Yopp AC; Marrero JA; Singal AG
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e267-e288. PubMed ID: 33387668
[TBL] [Abstract][Full Text] [Related]
25. Contribution of Geographic Location to Disparities in Ovarian Cancer Treatment.
Villanueva C; Chang J; Bartell SM; Ziogas A; Bristow R; Vieira VM
J Natl Compr Canc Netw; 2019 Nov; 17(11):1318-1329. PubMed ID: 31693984
[TBL] [Abstract][Full Text] [Related]
26. Dissecting disease, race, ethnicity, and socioeconomic factors for hepatocellular carcinoma: An analysis from the United States Safety Net Collaborative.
Lee RM; Gamboa AC; Turgeon MK; Yopp A; Ryon EL; Kronenfeld JP; Goel N; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Maithel SK; Russell MC
Surg Oncol; 2020 Dec; 35():120-125. PubMed ID: 32871546
[TBL] [Abstract][Full Text] [Related]
27. Healthcare disparities in Asians and Pacific Islanders with hepatocellular cancer.
Wong LL; Hernandez B; Kwee S; Albright CL; Okimoto G; Tsai N
Am J Surg; 2012 Jun; 203(6):726-32. PubMed ID: 22227170
[TBL] [Abstract][Full Text] [Related]
28. Variations in Receipt of Curative-Intent Surgery for Early-Stage Non-Small Cell Lung Cancer (NSCLC) by State.
Sineshaw HM; Wu XC; Flanders WD; Osarogiagbon RU; Jemal A
J Thorac Oncol; 2016 Jun; 11(6):880-9. PubMed ID: 26980472
[TBL] [Abstract][Full Text] [Related]
29. Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma.
Swords DS; Newhook TE; Tzeng CD; Massarweh NN; Chun YS; Lee S; Kaseb AO; Ghobrial M; Vauthey JN; Tran Cao HS
Ann Surg Oncol; 2023 Nov; 30(12):7309-7318. PubMed ID: 37679537
[TBL] [Abstract][Full Text] [Related]
30. Association between neutrophil-lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinoma.
Zhang Y; Brodin NP; Ohri N; Thibaud S; Kaubisch A; Kinkhabwala M; Garg M; Guha C; Kabarriti R
Hepatol Int; 2019 Sep; 13(5):609-617. PubMed ID: 31372942
[TBL] [Abstract][Full Text] [Related]
31. Decreasing disparity in liver transplantation among white and Asian patients with hepatocellular carcinoma : California, 1998-2005.
Robbins AS; Daily MF; Aoki CA; Chen MS; Troppmann C; Perez RV
Cancer; 2008 Oct; 113(8):2173-9. PubMed ID: 18792066
[TBL] [Abstract][Full Text] [Related]
32. Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007.
Robbins AS; Cox DD; Johnson LB; Ward EM
Cancer; 2011 Oct; 117(19):4531-9. PubMed ID: 21448933
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact.
Govalan R; Luu M; Lauzon M; Kosari K; Ahn JC; Rich NE; Nissen N; Roberts LR; Singal AG; Yang JD
Hepatol Commun; 2022 Jan; 6(1):223-236. PubMed ID: 34558830
[TBL] [Abstract][Full Text] [Related]
34. Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective.
Li JW; Goh BG; Chang PE; Tan CK
World J Gastroenterol; 2017 Jun; 23(22):4054-4063. PubMed ID: 28652658
[TBL] [Abstract][Full Text] [Related]
35. Socioeconomic and racial/ethnic disparities in receipt of palliative care among patients with metastatic hepatocellular carcinoma.
Alterio RE; Ju MR; Wang SC; Mansour JC; Yopp A; Porembka MR
J Surg Oncol; 2021 Dec; 124(8):1365-1372. PubMed ID: 34505295
[TBL] [Abstract][Full Text] [Related]
36. Rural-Urban Geographical Disparities in Hepatocellular Carcinoma Incidence Among US Adults, 2004-2017.
Wong RJ; Saab S; Konyn P; Sundaram V; Khalili M
Am J Gastroenterol; 2021 Feb; 116(2):401-406. PubMed ID: 32976121
[TBL] [Abstract][Full Text] [Related]
37. Head and Neck Cancer Stage at Presentation and Survival Outcomes Among Native Hawaiian and Other Pacific Islander Patients Compared With Asian and White Patients.
Moon PK; Ma Y; Megwalu UC
JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):636-645. PubMed ID: 35616952
[TBL] [Abstract][Full Text] [Related]
38. Older Patients With Hepatocellular Carcinoma Have More Advanced Disease, Lower Rates of Treatment, and Lower Survival.
Yan M; Ha J; Aguilar M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2017 Apr; 51(4):378-383. PubMed ID: 27380460
[TBL] [Abstract][Full Text] [Related]
39. Disparities in Hepatocellular Carcinoma Incidence in California: An Update.
Sangaramoorthy M; Yang J; DeRouen MC; Ho C; Somsouk M; Tana MM; Thompson CA; Gibbons J; Gomez SL; Shariff-Marco S
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):79-87. PubMed ID: 31719066
[TBL] [Abstract][Full Text] [Related]
40. Disparities in hepatocellular carcinoma survival among Californians of Asian ancestry, 1988 to 2007.
Kwong SL; Stewart SL; Aoki CA; Chen MS
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2747-57. PubMed ID: 20823106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
